sparfloxacin has been researched along with Urinary Tract Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blango, MG; Mulvey, MA | 1 |
| di Silverio, F; Geddes, A; Guibert, J; Naber, KG | 1 |
| Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL | 1 |
| Dorr, MB; Ellison, W; Henry, D; Magner, DJ; Mansfield, DL; Sullivan, J; Talbot, GH | 1 |
| Kumon, H; Monden, K; Nasu, Y; Ohmori, H; Tsugawa, M | 1 |
| Acusta, A; Dorr, MB; Dowzicky, M; Nadler, H; Talbot, GH | 1 |
| Dorr, MB; Henry, DC; Iravani, A; Magner, DJ; Mansfield, DL; Nenad, RC; Talbot, GH; Tice, AD | 1 |
| Hooper, DC | 2 |
| Hibi, H; Horiba, M; Nagakubo, I; Naide, Y; Okishio, N; Shinoda, M; Suzuki, K; Yanagioka, M | 1 |
| Kashimoto, S; Kojima, T; Kouno, K; Kurobe, N; Minami, A; Nakamura, S; Nakata, K; Ohue, T; Sakaguchi, Y; Yoshida, H | 1 |
3 review(s) available for sparfloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections | 1998 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sensitivity and Specificity; Sexually Transmitted Diseases; Urinary Tract Infections | 2000 |
The fluoroquinolones after ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections | 2000 |
5 trial(s) available for sparfloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Escherichia coli Infections; Female; Fluoroquinolones; Humans; International Cooperation; Male; Middle Aged; Quinolones; Urinary Tract Infections | 1996 |
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urinary Tract Infections | 1998 |
Prospective randomized comparative study of antibiotic prophylaxis in urethrocystoscopy and urethrocystography.
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Cystoscopy; Female; Fleroxacin; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Urinary Tract Infections; Urography | 1998 |
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1999 |
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 1999 |
3 other study(ies) available for sparfloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
[Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection].
Topics: Adult; Anti-Infective Agents; Bacteria; Cystitis; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Urinary Tract Infections | 1991 |
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Lung Diseases; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Skin Diseases, Infectious; Urinary Tract Infections | 1989 |